TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN COMBINATION THERAPY Application WO-2021175924-A1 World Intellectual Property Organisation (WIPO) 10 Sep 2021